MedTrace Logo

BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction

NCT04528511 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 774

Last updated 2026-03-19

No results posted yet for this study

Summary

To validate the prognostic importance of the burden of new-onset atrial fibrillation (NOAF) complicating acute myocardial infarction (AMI) in a prospectively designed hospital-based registry. To characterize those factors that contribute to the progression of post-MI NOAF burden. To establish a prediction model for the risk stratification of patients with NOAF complicating AMI. To explore the clinical usefulness of NOAF burden in guiding the anticoagulation therapy among patients with post-MI NOAF.

Conditions

  • Atrial Fibrillation New Onset
  • Acute Myocardial Infarction

Interventions

DEVICE

Continuous Electronic Monitor

All patients with NOAF complicating AMI will receive at least 5 days electronic monitoring for the evaluation of NOAF burden

Sponsors & Collaborators

  • Shanghai Tong Ren Hospital

    collaborator OTHER

  • Kaifeng Central Hospital

    collaborator OTHER

  • Shanghai 7th People's Hospital

    collaborator OTHER

  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER

  • Luoyang Central Hospital

    collaborator OTHER

  • Shanghai 10th People's Hospital

    lead OTHER

Principal Investigators

  • Yidong Wei, M.D., Ph.D. · Department of Cardiology, Shanghai Tenth People's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2027-12-31
Completion
2028-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04528511 on ClinicalTrials.gov